Interview with Jamil El-Imad CEO of NeuroPro

: in this interview Jamil El-Ima shares insights on how VR and AI are rapidly transforming healthcare, particularly in rehabilitation, mental health therapy, and patient education.

What motivated your decision to relocate from London to the UAE? How do you perceive the region’s potential for growth in AI, VR, and neuroscience?

My decision to relocate from London to the UAE was driven by both personal and professional motivations. I’ve always felt connected to the Gulf region through friendships and professional engagements. I’ve contributed to initiatives like the Dubai Future Foundation’s Global 50 report and worked on an AI and VR e-government project.
Professionally, the UAE’s rapid technological advancements and bold vision for the future resonate deeply with my passion for disruptive tech. The country’s commitment to becoming a global leader in AI and other emerging technologies, exemplified by initiatives like the National AI Strategy 2031, highlights its ambition to shape the future of technology.

Can you share more details about the technology consultancy you’re spearheading in the UAE? What specific challenges and opportunities do you see for C-Level executives in this region?

My work is driven by a belief in the transformative power of technology and a commitment to supporting the UAE’s ambitious vision for the future.

I aim to help organisations navigate disruptive technologies, particularly AI, VR, and neuroscience, by aligning these innovations with business goals to enhance decision-making, efficiency, and customer engagement.
In AI, I’ll focus on strategies like predictive analytics and machine learning; in VR, I’ll guide integration in areas like training and customer interactions, especially in sectors like education and healthcare.

Can you share any recent advancements from Neuropro in this area?

Artificial intelligence is set to revolutionise healthcare, especially in managing neurological and mental health disorders.
It has the potential to transform diagnosis, treatment, and even prediction of diseases, while advancing our understanding of the human brain, one of the least understood areas of biology.
I’ve been working on AI algorithms for diagnosing and predicting conditions like epilepsy at NeuroPro and with the Institute of Bio-Medical Engineering at Imperial College.
We’ve also developed the first neural stethoscope and VR-powered brain-computer interfaces for focus training and mental health and launched two digital health platforms for remote diagnostics and brain data collection, currently used by hospitals in Switzerland.

What are the key healthcare trends you observe in the UAE and the broader Middle East? How do these trends influence your approach to integrating AI and digital health solutions in the region?
The healthcare landscape in the UAE and the broader Middle East is transforming, driven by trends such as digitisation, telemedicine, and remote diagnostics.
The UAE is leading this shift, with companies like PureHealth and others spearheading innovation and adoption of digital health solutions, positioning the country as a regional and global leader in healthcare.
What excites me most is seeing senior executives embrace and champion these changes.
In my experience, business-led technology adoption succeeds, while technology-led deployments often fail.
In the UAE, government investments in digital infrastructure are enabling AI-driven solutions, and improving remote consultations, digital records, and patient management systems.
As digitisation progresses, AI’s effectiveness will increase, leading to advanced diagnostic tools and virtual health platforms that enhance patient care.

Viewed By: